current Opinion

Current Opinion

The Current Opinion series of journal titles each publish six specially commissioned themed issues annually by world-leading scientists and provide in-depth reviews of their field in the past 12 months. The series has been developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. Elsevier’s Current Opinion journals comprise of 12 leading titles in life sciences and adjacent fields.

Current Opinion in Environmental Sustainability

Editors-in-Chief::Eduardo Brondizio
Impact Factor: 3.491

Current Opinion in Genetics & Development

USD 330.00
Co-Editors-in-Chief::Marnie Halpern
Impact Factor: 7.574

Product Gallery

Current Opinion in Immunology

USD 333.00
Editors-in-Chief::Frederick Alt
Impact Factor: 7.478

Current Opinion in Cell Biology

USD 333.00
Editors:Tom Misteli
Impact Factor: 8.467

Current Opinion in Biotechnology

USD 336.00
Editor:Greg Stephanopoulos
Impact Factor: 7.117

Current Opinion in Neurobiology

USD 342.00
Editors:Ben Barres
Impact Factor: 6.628

Current Opinion in Structural Biology

USD 333.00
Editors::Keith Moffat
Impact Factor: 7.201

Current Opinion in Pharmacology

USD 336.00
Editors-in-Chief::T.P. Kenakin
Impact Factor: 4.595